U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Global Commissioning & Qualification Expert

Regulatory & Quality (Life Sciences)Updated on Nov 14
Full-timeBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • A bachelor's or master's degree in Engineering, Life Sciences, or a related technical discipline.
  • Strong expertise in Commissioning & Qualification for facilities, utilities, equipment, and computerized systems.
  • Deep knowledge of current Good Manufacturing Practice (cGMP), FDA requirements, EU Annex 15, ICH, ISPE guidance, and ASTM E2500 principles.
  • Experience within pharmaceutical or biopharmaceutical CAPEX project environments.
  • Proven ability to lead global initiatives and influence stakeholders within matrix organizations.
  • Professional proficiency in English.

Responsibilities

  • Define and maintain global Commissioning & Qualification standards, procedures, templates, and governance.
  • Support major CAPEX projects with compliant, efficient, and risk-based Commissioning & Qualification strategies.
  • Work with engineering, quality, and site teams to harmonize qualification methodologies globally.
  • Lead continuous improvement initiatives and strengthen commissioning integration into qualification activities.
  • Promote digitalization, paperless validation, smart commissioning, and innovative qualification solutions.
  • Act as UCB’s global Commissioning & Qualification expert during audits, inspections, risk assessments, and industry forums.
  • Lead and connect a global network of commissioning and qualification professionals, fostering best-practice sharing and consistent execution across UCB sites worldwide.

Desired Qualifications

  • French language skills are considered an advantage.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs